Clinical Trial Update: UC-MSC Transplantation for Left Ventricular Dysfunction After AMI [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating transplantation of umbilical cord-derived mesenchymal stem cells (UC-MSC) for left ventricular dysfunction after acute myocard…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Left Ventricular Dysfunction
• Myocardial Infarction

Drugs mentioned

• UC-MSC transplantation (Umbilical Cord-derived Mesenchymal Stem Cells)

Snippet

Sponsor: Shanghai Life Science & Technology | Conditions: Left Ventricular Dysfunction, Acute Myocardial Infarction | Phase 1 | Status: UNKNOWN